{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:33:43Z","timestamp":1722335623322},"reference-count":25,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,11,28]]},"DOI":"10.1536\/ihj.20-328","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T22:07:14Z","timestamp":1605218834000},"page":"1157-1164","source":"Crossref","is-referenced-by-count":3,"title":["Intraprocedural Conversion Efficacy of Intravenous Nifekalant Administration for Persistent Atrial Fibrillation after Pulmonary Vein Isolation"],"prefix":"10.1536","volume":"61","author":[{"given":"Chengye","family":"Di","sequence":"first","affiliation":[{"name":"Cardiac Electrophysiology Unit, First Department of Cardiology, TEDA International Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[{"name":"Cardiac Electrophysiology Unit, First Department of Cardiology, TEDA International Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiac Electrophysiology Unit, First Department of Cardiology, TEDA International Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxi","family":"Wu","sequence":"additional","affiliation":[{"name":"Cardiac Electrophysiology Unit, First Department of Cardiology, TEDA International Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Lin","sequence":"additional","affiliation":[{"name":"Cardiac Electrophysiology Unit, First Department of Cardiology, TEDA International Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chen S, Schmidt B, Bordignon S, <i>et al<\/i>. Atrial fibrillation ablation using cryoballoon technology: Recent advances and practical techniques. J Cardiovasc Electrophysiol 2018; 29: 932-43.","DOI":"10.1111\/jce.13607"},{"key":"2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.hrthm.2017.10.038","volume":"15","year":"2018","unstructured":"2. Tondo C, Iacopino S, Pieragnoli P, <i>et al<\/i>. Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project. Heart Rhythm 2018; 15: 363-8.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/europace\/euz313","volume":"22","year":"2020","unstructured":"3. Sawhney V, Schilling RJ, Providencia R, <i>et al<\/i>. Cryoablation for persistent and longstanding persistent atrial fibrillation: Results from a multicentre European registry. Europace 2020; 22: 375-81.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kuck KH, Brugada J, F\u00fcrnkranz A, <i>et al<\/i>. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016; 374: 2235-45.","DOI":"10.1056\/NEJMoa1602014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dixit S, Marchlinski FE, Lin D, <i>et al<\/i>. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol 2012; 5: 287-94.","DOI":"10.1161\/CIRCEP.111.966226"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gaita F, Caponi D, Scaglione M, <i>et al<\/i>. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008; 1: 269-75.","DOI":"10.1161\/CIRCEP.108.774885"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Verma A, Jiang CY, Betts TR, <i>et al<\/i>. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015; 372: 1812-22.","DOI":"10.1056\/NEJMoa1408288"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mont L, Bisbal F, Hern\u00e1ndez-Madrid A, <i>et al<\/i>. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: A multicentre, randomized, controlled trial (SARA study). Eur Heart J 2014; 35: 501-7.","DOI":"10.1093\/eurheartj\/eht457"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wong KC, Paisey JR, Sopher M, <i>et al<\/i>. No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: Benefit of complex ablation study. Circ Arrhythm Electrophysiol 2015; 8: 1316-24.","DOI":"10.1161\/CIRCEP.114.002504"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fink T, Schl\u00fcter M, Heeger CH, <i>et al<\/i>. Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: The Randomized Alster-Lost-AF Trial (ablation at St. Georg Hospital for long-standing persistent atrial fibrillation). Circ Arrhythm Electrophysiol 2017; 10: e005114.","DOI":"10.1161\/CIRCEP.117.005114"},{"key":"11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/europace\/euv351","volume":"18","year":"2016","unstructured":"11. Scott PA, Silberbauer J, Murgatroyd FD. The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: A meta-analysis. Europace 2016; 18: 359-67.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kawaji T, Shizuta S, Yamagami S, <i>et al<\/i>. Clinical utility of intravenous nifekalant injection during radiofrequency catheter ablation for persistent atrial fibrillation. J Atr Fibrillation 2018; 11: 1839.","DOI":"10.4022\/jafib.1839"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kumagai K, Toyama H. Usefulness of ablation of complex fractionated atrial electrograms using nifekalant in persistent atrial fibrillation. J Cardiol 2013; 61: 44-8.","DOI":"10.1016\/j.jjcc.2012.08.015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tokutake K, Tokuda M, Yamashita S, <i>et al<\/i>. Anatomical and procedural factors of severe pulmonary vein stenosis after cryoballoon pulmonary vein ablation. JACC Clin Electrophysiol 2019; 5: 1303-15.","DOI":"10.1016\/j.jacep.2019.08.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Straube F, Hartl S, Dorwarth U, <i>et al<\/i>. Cryoballoon ablation for persistent atrial fibrillation - Large single-center experience. J Cardiol 2016; 68: 492-7.","DOI":"10.1016\/j.jjcc.2016.02.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Omran H, Gutleben KJ, Molatta S, <i>et al<\/i>. Second generation cryoballoon ablation for persistent atrial fibrillation: An updated meta-analysis. Clin Res Cardiol 2018; 107: 182-92.","DOI":"10.1007\/s00392-017-1171-5"},{"key":"17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hrthm.2014.09.063","volume":"12","year":"2015","unstructured":"17. Ciconte G, Ottaviano L, de Asmundis C, <i>et al<\/i>. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: One-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm 2015; 12: 60-6.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.hrthm.2019.12.006","volume":"17","year":"2020","unstructured":"18. Guckel D, Schmidt A, Gutleben KJ, <i>et al<\/i>. Pulmonary vein isolation and beyond: Predictive value of vagal reactions in second-generation cryoballoon ablation for the outcome of persistent atrial fibrillation. Heart Rhythm 2020; 17: 600-6.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Watanabe H, Watanabe I, Nakai T, <i>et al<\/i>. Frequency-dependent electrophysiological effects of flecainide, nifekalant and d, l-sotalol on the human atrium. Jpn Circ J 2001; 65: 1-6.","DOI":"10.1253\/jcj.65.1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Minami T, Isomoto S, Nakao K, <i>et al<\/i>. Effects of intravenous nifekalant, a class III antiarrhythmic drug, on atrial vulnerability parameters in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2004; 27: 212-7.","DOI":"10.1111\/j.1540-8159.2004.00412.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sasaki N, Watanabe I, Kogawa R, <i>et al<\/i>. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation. Int Heart J 2014; 55: 244-8.","DOI":"10.1536\/ihj.13-254"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Morita N, Tanaka K, Yodogawa K, <i>et al<\/i>. Effect of nifekalant for acute conversion of atrial flutter: The possible termination mechanism of typical atrial flutter. Pacing Clin Electrophysiol 2007; 30: 1242-53.","DOI":"10.1111\/j.1540-8159.2007.00846.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Suzuki M, Nagahori W, Mizukami A, Matsumura A, Hashimoto Y. A multicenter observational study of the effectiveness of antiarrhythmic agents in ventricular arrhythmias: A propensity-score adjusted analysis. J Arrhythm 2016; 32: 186-90.","DOI":"10.1016\/j.joa.2016.01.004"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Njoku A, Kannabhiran M, Arora R, <i>et al<\/i>. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis. Europace 2018; 20: 33-42.","DOI":"10.1093\/europace\/eux013"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Koh\u00e1ri M, Zado E, Marchlinski FE, Callans DJ, Han Y. Left atrial volume best predicts recurrence after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation. Pacing Clin Electrophysiol 2014; 37: 422-9.","DOI":"10.1111\/pace.12279"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/6\/61_20-328\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:46:07Z","timestamp":1606535167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/6\/61_20-328\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-328","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}